Gene silencing of hPRLR mRNA by RNA interference in human breast cancer cells

Related Experiment Video

Updated: Jun 2, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Qinjun Wei1, Yajie Lu, Mei Pan

  • 1Department of Biotechnology, Nanjing Medical University, Nanjing 210029, P.R. China.

Molecular Medicine Reports
|April 12, 2011
PubMed

Insights

Small interfering RNA (siRNA) targeting the human prolactin receptor (hPRLR) effectively inhibited breast cancer cell proliferation. This RNA interference (RNAi) approach shows therapeutic potential for breast cancer by targeting hPRLR overexpression.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Aberrant signaling of the human prolactin receptor (hPRLR) is linked to abnormal breast epithelial cell proliferation.
  • Overexpression of hPRLR is implicated in breast cancer development.

Purpose of the Study:

  • To evaluate the efficacy of small-interfering RNA (siRNA) targeting hPRLR for inhibiting T-47D breast cancer cell proliferation.
  • To assess the anti-tumor potential of hPRLR-targeted RNA interference (RNAi).

Main Methods:

  • Chemically synthesized hPRLR-targeted siRNA were cloned into a pSilencer 2.0 vector.
  • Gene expression was analyzed using real-time quantitative PCR and Western blot.
  • Cell proliferation was measured by MTT assay, and cell cycle distribution was analyzed.

Main Results:

  • The hPRLR siRNA plasmid significantly reduced hPRLR gene expression in T-47D cells.
  • siRNA treatment decreased cell growth rate and reduced the proportion of cells in the G2/M phase.
  • A significant increase in cells within the G0/G1 phase was observed post-treatment.

Conclusions:

  • RNAi-mediated silencing of the hPRLR gene specifically inhibits the proliferation of T-47D breast cancer cells.
  • Targeting hPRLR overexpression via RNAi presents a potential therapeutic strategy for breast cancer.
  • hPRLR is identified as a potential therapeutic target for breast cancer treatment.

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

DNA Vector-based RNA Interference to Study Gene Function in Cancer13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...